Breaking News Instant updates and real-time market news.

ZS

Zscaler

$44.46

-1.37 (-2.99%)

, MSFT

Microsoft

$150.35

0.4 (0.27%)

17:51
11/18/19
11/18
17:51
11/18/19
17:51

Zscaler initiated with a Buy at DA Davidson

DA Davidson analyst Andrew Nowinski initiated coverage of Zscaler (ZS) with a Buy rating and $55 price target. The analyst notes that the company is faced with near-term concerns related to the global macro backdrop and the potential disruption from the recent transition of head of sales change, but he sees its move to the cloud, tailwinds from the Microsoft (MSFT) partnership, SD-WAN adoption, and the growing opportunity in the Public Sector vertical offsetting these issues.

ZS

Zscaler

$44.46

-1.37 (-2.99%)

MSFT

Microsoft

$150.35

0.4 (0.27%)

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 09

    Dec

  • 16

    Dec

ZS Zscaler
$44.46

-1.37 (-2.99%)

10/14/19
SBSH
10/14/19
INITIATION
Target $50
SBSH
Neutral
Zscaler initiated with a Neutral at Citi
Citi analyst Walter Pritchard initiated coverage of Zscaler with a Neutral rating and $50 price target. The analyst sees identity management becoming more strategic as companies move to cloud. Historical identity management spend that has gone to the infrastructure providers is now "up for grabs," says Pritchard.
10/14/19
SBSH
10/14/19
INITIATION
SBSH
Citi expands Software coverage with two Buys and one Sell
Citi analyst Walter Pritchard expanded his Security coverage by initiating Okta (OKTA) and Ping Identity (PING) with Buy ratings, Zscaler (ZS) with a Neutral rating, and Crowdstrike (CRWD) with a Sell rating. While Crowdstrike's recent growth has generated a lot of excitement, its market opportunity is largely pegged to the end-point security market, where peak leadership share has been around 10%, Pritchard tells investors in a research note. He believes the company's expansion into adjacencies will be challenging "as they are crowded already." The analyst sees potential for Ping Identity's growth to accelerate and believes Okta's "aggressive" product roadmap should enable the company to capitalize on an underestimated total addressable market. On Zscaler, the analyst sees a "still lofty multiple" and balanced risk/reward profile.
11/12/19
GSCO
11/12/19
INITIATION
Target $45
GSCO
Neutral
Zscaler initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Brian Essex initiated coverage of Zscaler with a Neutral rating and $45 price target. The analyst started the Security Software sector with an attractive view, believing IT Security offers "attractive levels of exposure to growth technology," and that profitable companies with this exposure could outperform the market. He views Zscaler as a leading provider of web security technology well positioned to take advantage of a shift in security spending. However, the stock's current multiple is "elevated," contends Essex.
11/18/19
DADA
11/18/19
INITIATION
DADA
Buy
Zscaler initiated with a Buy at DA Davidson
DA Davidson analyst Andrew Nowinski initiated coverage of Zscaler with a Buy rating.
MSFT Microsoft
$150.35

0.4 (0.27%)

11/01/19
NEED
11/01/19
DOWNGRADE
NEED
Hold
Arista Networks downgraded to Hold from Buy at Needham
Needham analyst Alex Henderson downgraded Arista Networks (ANET) to Hold from Buy after its "weak" Q4 guidance, saying this marks the 3rd consecutive quarter of a cut in outlook. The analyst notes that while the prior delay in orders from Microsoft (MSFT) has now come back, another larger customer - "most likely" Facebook (FB) - has sharply reduced its orders from Arista over the span of multiple quarters. Henderson adds that the reduction in outlook, along with the "unpredictability" of cloud demand, are likely to hurt valuations even when demand recovers.
11/05/19
RSBL
11/05/19
UPGRADE
Target $13
RSBL
Buy
Applied Optoelectronics upgraded to Buy ahead of guidance at Rosenblatt
As previously reported, Rosenblatt analyst Jun Zhang upgraded Applied Optoelectronics (AAOI) to Buy from Neutral with a price target of $13, up from $10. When the company reports Q3 results tomorrow, Zhang believes it will provide guidance for sequential revenue growth in Q4, powered by Microsoft's (MSFT) increasing demand for 100G products and demand from Amazon (AMZN) for 40G products. In addition to demand in the U.S. hyperscale market, Zhang sees Applied benefiting in 2020 from potential opportunities in 5G, a likely design wins at ZTE (ZTCOY), and potential opportunities to supply to Cisco (CSCO) clients.
11/07/19
MZHO
11/07/19
NO CHANGE
Target $20
MZHO
Neutral
Slack Technologies price target lowered to $20 from $24 at Mizuho
Mizuho analyst Gregg Moskowitz lowered his price target for Slack Technologies (WORK) to $20 from $24 and keeps a Neutral rating on the shares. The analyst says that while he continues to view Slack's communications/collaboration platform as "best-in-class," he's observed "strong fundamental progress" of Microsoft Teams (MSFT) over the past 12 months. Despite a material recent selloff in Slack shares, Moskowitz has an increased level of concern with respect to Microsoft Teams as a competitive threat to the company going forward following Microsoft's Ignite conference. He keeps a Neutral rating on Slack Technologies.
11/18/19
COWN
11/18/19
NO CHANGE
Target $185
COWN
Outperform
Salesforce remains a top pick ahead of Dreamforce, says Cowen
Cowen analyst J. Derrick Wood said Salesforce (CRM) remains a top pick ahead of is Dreamforce show and subsequent analyst day. The analyst expects a normal show with nothing too incremental but he sees three things that could be positive catalysts; an update to revenue guidance, more details around its Tableau (DATA) acquisition, and color around its Microsoft (MSFT) partnership that was announced last week. Wood reiterated his Outperform rating and $185 price target on Salesforce shares.

TODAY'S FREE FLY STORIES

STIM

Neuronetics

$4.55

0.05 (1.11%)

, SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

05:53
12/06/19
12/06
05:53
12/06/19
05:53
Recommendations
Neuronetics, Sage Therapeutics analyst commentary  »

Piper reiterates…

STIM

Neuronetics

$4.55

0.05 (1.11%)

SAGE

Sage Therapeutics

$60.11

-89.11 (-59.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COO

Cooper Companies

$313.10

1 (0.32%)

05:47
12/06/19
12/06
05:47
12/06/19
05:47
Recommendations
Cooper Companies analyst commentary  »

Cooper Companies should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 13

    Dec

CRWD

Crowdstrike

$53.00

-2.04 (-3.71%)

05:45
12/06/19
12/06
05:45
12/06/19
05:45
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

FRPT

Freshpet

$57.40

2.57 (4.69%)

05:43
12/06/19
12/06
05:43
12/06/19
05:43
Recommendations
Freshpet analyst commentary  »

Freshpet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

05:42
12/06/19
12/06
05:42
12/06/19
05:42
Recommendations
Biohaven Pharmaceutical analyst commentary  »

Biohaven should be owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AQUA

Evoqua Water

$19.02

-0.09 (-0.47%)

05:31
12/06/19
12/06
05:31
12/06/19
05:31
Downgrade
Evoqua Water rating change  »

Evoqua Water downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

$138.19

3.26 (2.42%)

05:29
12/06/19
12/06
05:29
12/06/19
05:29
Initiation
Mohawk initiated  »

Mohawk initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOS

A.O. Smith

$46.89

0.53 (1.14%)

05:28
12/06/19
12/06
05:28
12/06/19
05:28
Initiation
A.O. Smith initiated  »

A.O. Smith initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$52.16

0.33 (0.64%)

05:27
12/06/19
12/06
05:27
12/06/19
05:27
Initiation
Leggett & Platt initiated  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OC

Owens Corning

$66.07

0.69 (1.06%)

05:26
12/06/19
12/06
05:26
12/06/19
05:26
Initiation
Owens Corning initiated  »

Owens Corning initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JELD

Jeld-Wen

$23.15

0.47 (2.07%)

05:25
12/06/19
12/06
05:25
12/06/19
05:25
Initiation
Jeld-Wen initiated  »

Jeld-Wen initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$46.01

0.445 (0.98%)

05:23
12/06/19
12/06
05:23
12/06/19
05:23
Initiation
Masco initiated  »

Masco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBP

Installed Building Products

$71.67

1.12 (1.59%)

05:22
12/06/19
12/06
05:22
12/06/19
05:22
Initiation
Installed Building Products initiated  »

Installed Building…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBHS

Fortune Brands

$63.90

0.74 (1.17%)

05:22
12/06/19
12/06
05:22
12/06/19
05:22
Initiation
Fortune Brands initiated  »

Fortune Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$144.83

2.825 (1.99%)

05:20
12/06/19
12/06
05:20
12/06/19
05:20
Initiation
Whirlpool initiated  »

Whirlpool initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jan

AWI

Armstrong World

$93.35

-0.87 (-0.92%)

05:19
12/06/19
12/06
05:19
12/06/19
05:19
Initiation
Armstrong World initiated  »

Armstrong World initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIEN

Ciena

$36.30

-0.3 (-0.82%)

, FB

Facebook

$199.35

0.65 (0.33%)

05:17
12/06/19
12/06
05:17
12/06/19
05:17
Downgrade
Ciena, Facebook, AT&T rating change  »

Ciena downgraded to Sell…

CIEN

Ciena

$36.30

-0.3 (-0.82%)

FB

Facebook

$199.35

0.65 (0.33%)

T

AT&T

$38.21

0.07 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 29

    Jan

RDY

Dr. Reddy's

$40.11

-0.03 (-0.07%)

05:15
12/06/19
12/06
05:15
12/06/19
05:15
Hot Stocks
Dr. Reddy's announces launch of Deferasirox Film-Coated Tablets in U.S. market »

Dr. Reddy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$40.90

0.79 (1.97%)

05:14
12/06/19
12/06
05:14
12/06/19
05:14
Initiation
Toll Brothers initiated  »

Toll Brothers initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PHM

PulteGroup

$40.19

0.79 (2.01%)

05:13
12/06/19
12/06
05:13
12/06/19
05:13
Initiation
PulteGroup initiated  »

PulteGroup initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTH

Meritage Homes

$67.01

0.755 (1.14%)

05:12
12/06/19
12/06
05:12
12/06/19
05:12
Initiation
Meritage Homes initiated  »

Meritage Homes initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEN

Lennar

$59.82

0.96 (1.63%)

05:11
12/06/19
12/06
05:11
12/06/19
05:11
Initiation
Lennar initiated  »

Lennar initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$35.11

0.575 (1.67%)

05:10
12/06/19
12/06
05:10
12/06/19
05:10
Initiation
KB Home initiated  »

KB Home initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHI

D.R. Horton

$55.73

0.38 (0.69%)

05:09
12/06/19
12/06
05:09
12/06/19
05:09
Initiation
D.R. Horton initiated  »

D.R. Horton initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SUM

Summit Materials

$23.60

-0.48 (-1.99%)

05:06
12/06/19
12/06
05:06
12/06/19
05:06
Downgrade
Summit Materials rating change  »

Summit Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.